Liberta RC™ deep brain stimulation (DBS) system, recently approved by the U.S. FDA, features NeuroSphere™ Virtual Clinic, which allows for remote programming of the system System offers the longest ...

Abbott Laboratories (NYSE:ABT) received FDA approval to launch the Liberta RC DBS system, the world’s smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people ...

Credit: Abbott. Liberta RC DBS is the smallest rechargeable DBS device featuring the NeuroSphere Virtual Clinical, which allows for remote programming capabilities. The Food and Drug Administration ...

Abbott has received U.S. Food & Drug Administration approval to launch a deep brain stimulation system (DBS) that the company touts as the world's smallest rechargeable device of its kind, the medical ...

Abbott’s Infinity Deep Brain Stimulation (DBS) system has received an expanded clearance from the FDA that now permits the targeted stimulation of a new area of the brain associated with Parkinson’s ...